Astrid Natalia Santamaría

Ms. Astrid Natalia Santamaría

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2025 in Cells
Verified
Journal Article
Open access
PDF file
Cristian Mera-AzainCristian Mera-Azain
Cristian Mera-Azain
Astrid Natalia SantamaríaAstrid Natalia Santamaría
Astrid Natalia Santamaría
TCTatiana Camila Castañeda
Tatiana Camila Castañeda
LULuis Fernando Useche
Luis Fernando Useche
EGEfraín Leal Garcia
Efraín Leal Garcia
Viviana Marcela Rodriguez-PardoViviana Marcela Rodriguez-Pardo
Viviana Marcela Rodriguez-Pardo
Articular cartilage regeneration remains a major challenge due to its limited self-repair capacity. Bone marrow-derived skeletal stem cells (SSCs) and mesenchymal stem cells (MSCs) are promising candidates for cartilage engineering, although they differ in their chondrogenic potential. This study explored whether co-culturing SSCs and MSCs in three-dimensional (3D) organoid systems under cartilage physioxia (5% O2) and chondrogenic induction could improve cartilage tissue formation. SSCs, MSCs, and SSC–MSC co-cultures were characterized for morphology, phenotype, and differentiation capacity. Organoids were generated and cultured for 10 days, followed by analysis of morphology, viability, gene expression (SOX9, RUNX2, ACAN, COL2A1, COL10A1, PRG4, and PDPN), chondrocyte-associated antigens (CD44, CD105, CD146, and PDPN), and cartilage ECM proteins (aggrecan, collagen types I, II, and X, and PRG4). SSCs showed robust chondrogenic and osteogenic potential, while MSCs exhibited a balanced multipotency. Co-culture-derived organoids enhanced chondrogenesis and reduced adipogenesis, with higher expression of cartilage-specific ECM and lower hypertrophic marker levels. These findings highlight the functional synergy between SSCs and MSCs in co-culture, promoting the formation of stable, cartilage-like structures under physioxia. The approach offers a promising strategy for generating preclinical models and advancing regenerative therapies for hyaline cartilage repair.

21 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Cristian Mera-AzainCristian Mera-Azain
Cristian Mera-Azain
Astrid Natalia SantamaríaAstrid Natalia Santamaría
Astrid Natalia Santamaría
TCTatiana Camila Castañeda
Tatiana Camila Castañeda
LULuis Fernando Useche
Luis Fernando Useche
EGEfrain Leal Garcia
Efrain Leal Garcia
Viviana Marcela Rodriguez-PardoViviana Marcela Rodriguez-Pardo
Viviana Marcela Rodriguez-Pardo
Articular cartilage regeneration remains a major challenge due to its limited self-repair capacity. Bone marrow-derived skeletal stem cells (SSCs) and mesenchymal stem cells (MSCs) are promising candidates for cartilage engineering, though they differ in their chondrogenic potential. This study explored whether co-culturing SSCs and MSCs in three-dimensional (3D) organoid systems under cartilage physioxia (5% O₂) and chon-drogenic induction could improve cartilage tissue formation. SSCs, MSCs, and SSC–MSC co-cultures were characterized for morphology, phenotype, and differentiation capacity. Organoids were generated and cultured for 10 days, followed by analysis of morphology, viability, gene expression (SOX9, RUNX2, ACAN, COL2A1, COL10A1, PRG4, and PDPN), chondrocyte-associated antigens (CD44, CD105, CD146, and PDPN), and cartilage ECM proteins (aggrecan, collagen types I, II, and X, and PRG4). SSCs showed robust chondrogenic and osteogenic potential, while MSCs exhibited a balanced multipotency. Co-culture-derived organoids enhanced chondrogenesis and reduced adipogenesis, with higher expression of cartilage-specific ECM and lower hy-pertrophic marker levels. These findings highlight the functional synergy between SSCs and MSCs in co-culture, promoting the formation of stable, cartilage-like struc-tures under physioxia. The approach offers a promising strategy for generating pre-clinical models and advancing regenerative therapies for hyaline cartilage repair.